Correlation Between Larimar Therapeutics and Bolt Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and Bolt Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and Bolt Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Larimar Therapeutics and Bolt Biotherapeutics, you can compare the effects of market volatilities on Larimar Therapeutics and Bolt Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of Bolt Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and Bolt Biotherapeutics.
Diversification Opportunities for Larimar Therapeutics and Bolt Biotherapeutics
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Larimar and Bolt is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and Bolt Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bolt Biotherapeutics and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with Bolt Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bolt Biotherapeutics has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and Bolt Biotherapeutics go up and down completely randomly.
Pair Corralation between Larimar Therapeutics and Bolt Biotherapeutics
Given the investment horizon of 90 days Larimar Therapeutics is expected to under-perform the Bolt Biotherapeutics. In addition to that, Larimar Therapeutics is 2.28 times more volatile than Bolt Biotherapeutics. It trades about -0.17 of its total potential returns per unit of risk. Bolt Biotherapeutics is currently generating about 0.04 per unit of volatility. If you would invest 63.00 in Bolt Biotherapeutics on September 1, 2024 and sell it today you would earn a total of 1.00 from holding Bolt Biotherapeutics or generate 1.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Larimar Therapeutics vs. Bolt Biotherapeutics
Performance |
| Timeline |
| Larimar Therapeutics |
| Bolt Biotherapeutics |
Larimar Therapeutics and Bolt Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Larimar Therapeutics and Bolt Biotherapeutics
The main advantage of trading using opposite Larimar Therapeutics and Bolt Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, Bolt Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bolt Biotherapeutics will offset losses from the drop in Bolt Biotherapeutics' long position.| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
| Bolt Biotherapeutics vs. Assembly Biosciences | Bolt Biotherapeutics vs. Instil Bio | Bolt Biotherapeutics vs. CytomX Therapeutics | Bolt Biotherapeutics vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |